Cargando…
Dual Impact of Tolvaptan on Intracellular and Extracellular Water in Chronic Kidney Disease Patients with Fluid Retention
Objective Tolvaptan, an oral selective V2-receptor antagonist, is a water diuretic that ameliorates fluid retention with a lower risk of a worsening renal function than conventional loop diuretics. Although loop diuretics predominantly decrease extracellular water (ECW) compared with intracellular w...
Autores principales: | Masuda, Takahiro, Murakami, Takuya, Igarashi, Yusuke, Okabe, Kyochika, Kobayashi, Takahisa, Takeda, Shin-ichi, Saito, Takako, Sekiguchi, Chuji, Miyazawa, Yasuharu, Akimoto, Tetsu, Saito, Osamu, Muto, Shigeaki, Nagata, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088534/ https://www.ncbi.nlm.nih.gov/pubmed/27725533 |
Ejemplares similares
-
Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease
por: Nagayama, Izumi, et al.
Publicado: (2019) -
A Supraglottic Pseudotumor in an Immunocompromised Patient with Nephrotic Syndrome, Herpes Zoster, and a Cytomegalovirus Infection
por: Akimoto, Tetsu, et al.
Publicado: (2016) -
Valacyclovir Neurotoxicity and Nephrotoxicity in an Elderly Patient Complicated by Hyponatremia
por: Murakami, Takuya, et al.
Publicado: (2018) -
Effects of Raloxifene on Bone Metabolism in Hemodialysis Patients With Type 2 Diabetes
por: Saito, Osamu, et al.
Publicado: (2012) -
Performing Anticoagulation: A Puzzling Case of Cholesterol Embolization Syndrome
por: Igarashi, Yusuke, et al.
Publicado: (2017)